SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 214 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,386 | -8.3% | 413 | 0.0% | 0.00% | – |
| Q2 2023 | $12,415 | -17.0% | 413 | 0.0% | 0.00% | – |
| Q1 2023 | $14,963 | +99653.3% | 413 | 0.0% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 413 | -17.2% | 0.00% | – |
| Q3 2022 | $17,000 | -43.3% | 499 | -51.0% | 0.00% | – |
| Q2 2022 | $30,000 | -3.2% | 1,018 | +4.6% | 0.00% | – |
| Q1 2022 | $31,000 | +6.9% | 973 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -95.1% | 973 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $595,000 | +24.0% | 19,000 | 0.0% | 0.02% | +16.7% |
| Q4 2016 | $480,000 | +2.1% | 19,000 | 0.0% | 0.02% | -5.3% |
| Q3 2016 | $470,000 | +21.4% | 19,000 | 0.0% | 0.02% | +18.8% |
| Q2 2016 | $387,000 | +33.4% | 19,000 | 0.0% | 0.02% | +33.3% |
| Q1 2016 | $290,000 | +28.3% | 19,000 | +13.1% | 0.01% | +20.0% |
| Q4 2015 | $226,000 | – | 16,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |